Nephron Protection in Diabetic Kidney Disease

N Engl J Med. 2016 Nov 24;375(21):2096-2098. doi: 10.1056/NEJMcibr1608564.
No abstract available

MeSH terms

  • Benzhydryl Compounds / therapeutic use
  • Diabetic Nephropathies / drug therapy*
  • Diabetic Nephropathies / physiopathology
  • Glomerular Filtration Rate
  • Glucosides / therapeutic use
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Nephrons / drug effects
  • Nephrons / physiopathology*
  • Sodium-Glucose Transporter 2 Inhibitors*

Substances

  • Benzhydryl Compounds
  • Glucosides
  • Hypoglycemic Agents
  • Sodium-Glucose Transporter 2 Inhibitors
  • empagliflozin